Background 30 Cutaneous squamous cell carcinomas (cSCC) are the primary cause of premature deaths in patients 31 suffering from the rare skin-fragility disorder recessive dystrophic epidermolysis bullosa, which is in marked 32 contrast to the rarely metastasizing nature of these carcinomas in the general population. This remarkable 33 difference is attributed to the frequent development of chronic wounds caused by an impaired skin integrity.
various landmark studies (13) (14) (15) . MiR-10b is encoded by a highly conserved genomic region, which is 84 located near the homeobox D (HOXD) cluster on chromosome 2 (16). It has been linked to a range of 85 functions, including regulation of angiogenesis and promotion of cell invasion (17) (18) (19) (20) . In addition, increased 86 serum levels of miR-10b are associated with poor prognosis in melanoma and breast cancer (21, 22) , and 87 intravenous injections of miR-10b inhibitors in tumor-bearing mice dramatically reduced breast cancer cell 88 metastasis (13, 15, 23) . In addition, a meta-analysis of miR-10b levels and clinical outcomes in various 89 cancers, demonstrated that overexpression was associated with poor overall survival, indicating that miR-90 10b might be a promising prognostic biomarker (24).
91
In this study, we substantially add to our understanding of the role of miR-10b, by reporting for the first time 92 on the dysregulation of this miRNA in aggressive cSCC. Both, RDEB-and otherwise healthy donor-related 93 cSCCs (HC-cSCCs) were classified and included in this study according to their potential to metastasize.
94
We further show that miR-10b expression is linked to a cancer stem cell-like phenotype in a 3D organotypic For this study, primary cells were used for microarray experiments, as well as for validations. For miR-10b 101 overexpression, we used HPV16 E6/E7 immortalized keratinocytes. All cells were cultured in defined, 102 serum-free CnT-Prime Epithelial Culture Medium (CELLnTEC) at 37°C / 5% CO2 in a humidified incubator.
103
For more detailed information regarding origin of the cell lines and donor description see Supplementary
104
Information and Supplementary Table S1 . For total RNA and miRNA isolation from cell cultures, we used miRNeasy Mini Kit (Qiagen, 217004), 108 according to manufacturer's protocol. For transcriptome analysis, an Affymetrix Clariom TM D (Thermo Fisher, 109 902922) was applied and an Affymetrix GeneChip TM miRNA 4.1 platform was used for miRNA analysis 110 (Thermo Fisher, 902409) . Arrays were performed by the service provider "Core Facility Genomics at the 111 Medical University Vienna" in accordance with manufacturer's instructions. RNA quality was confirmed on 112 a Bioanalyzer prior to hybridization onto a respective array. Quality assessment of microarray data was 113 conducted via "Transcriptome Analysis Console" (Applied Biosystems v4.0.0.25).
115
Bioinformatic data processing and statistical analysis 116 All data processing and analysis was documented and performed in statistical software R (v3.5.1). Scripts For primary (pri)-miRNA assays cDNA was synthesized from 1 µg total RNA. For reverse transcription, the 124 High Capacity RNA-to-cDNA kit (Applied Biosystems, 4387406) Table S2 ) and DAPI 151 were used for visualization and co-staining of cells and tissue section, respectively. Slides were mounted 152 using Prolong Gold Antifade mounting medium (Sigma, P36930).
153
Imaging was performed on a LSM800 Airyscan confocal microscope (Zeiss). Analysis was conducted in 154 ImageJ (v1.52i) and CellProfiler (v3.0.0) with all steps documented in scripts and workflow files, available 155 upon request. Cellular boundaries were detected based on respective fluorescence signals and signal 156 intensities were integrated at single cell resolution. To confine the analysis to cytoplasmic signals, nuclei 157 were demarked via DAPI staining and co-localizing fluorescence signals were subtracted from total 158 fluorescence. Downstream statistical analysis was performed in statistical software R (v3.5.1). antibodies, a respective second-step control was included. Secondary antibodies were used at a 1:500 170 dilution ( Supplementary Table S2 ). DAPI was used for nuclear staining (Sigma Aldrich, D9542). The same 171 protocol was used for cultured cells. There, about 3 × 10 4 cells were seeded into 1 cm 2 chamber slides.
160

172
After 24 hours (hrs) cells were fixed for 10 min in 4 % formaldehyde in PBS, washed once with PBS and Supplementary Table S3 . All constructs 180 were analyzed using Sanger sequencing before viral packaging.
181
Viral particle production using pMX_U6_miR10b was done as described previously (26 
188
A29377). Two primer sets were used for gRNA synthesis ( Supplementary Table S3 ). Recombinant spCas9 189 was purchased from Polyplus-transfection (Polyplus-transfection). Ribonucleoproteins (RNPs) were 190 complexed in a 4:1 ratio (3 µg spCas9 and 750 ng sgRNAs; 375 ng each sgRNA) for 10 min at room 191 temperature and delivered into RDEB-SCC1 keratinocytes by nucleofection using the Neon Transfection 
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Migration assay 199 Cell motility assays were performed using 2-well silicone inserts with a defined cell-free gap, suitable for 200 wound healing / migration assays (IBIDI, 80241). 7×10 4 cells in 70 µL CnT-Prime medium were seeded per 201 well. 24 hrs post seeding silicone inserts were removed and migration of cells was monitored at different 202 time points by measuring cell confluence in a pre-defined, constant area including the gap using a Spark ® 203 10M multimode microplate reader imaging module (Tecan). Gap-area was calculated using ImageJ (v1.52i).
204
In parallel to every migration assay, proliferation of each cell type was measured in 24-well plates, to exclude 205 varying proliferation rates as confounding factor.
207
Generation of 3D tumor spheroids 208 3D spheroids were grown as floating spheres in AggreWell™ 400Ex Plates 34425) 209 according to the manufacturer's recommendations. 2.35×10 5 cells / well were seeded in CnT-prime medium 210 supplemented with 1.2 mM CaCl2. Spheroids were grown for 96 hrs. Aggregates were transferred into a 24-211 well plate for imaging on a Spark ® 10M multimode microplate-reader with integrated imaging module 212 (Tecan). For live/dead stainings, aggregates were purified using Corning ® Costar ® Spin-X ® Centrifuge tube 213 filters (0.22 µm) (Corning, CLS8161-100EA). Viability was tested via live/dead viability/cytotoxicity kit 214 (Thermo Fisher, L3224). Imaging was performed on a Zeiss LSM710 confocal microscope. TECAN whole 215 well images were processed in ImageJ (v1.52i) software. All image processing was documented in ImageJ 216 macros and downstream statistical analysis in R (v3.5.1) scripts, which are available upon request.
217
For outgrowth experiments, spheroids were transferred to standard 24-well plates and incubated at 37°C in 
224
(TUBA1) were used as reference genes. For primers see Supplementary Table S3 . Data collection was 225 performed on a CFX96 (BioRad) instrument. Relative target gene expression quantities and significance 226 levels (unpaired two-sided t-test) were calculated using the Cq method. All reactions were performed in 227 technical duplicates, and performed in at least three independent experiments.
229
Western blot analysis 230 Protein extracts were generated from ~ 5×10 5 cells at a confluency of 80%, dissolved and homogenized in 231 RIPA buffer (Santa Cruz, sc-24948) supplemented with 5% ß-Mercaptoethanol (ß-ME). Proteins were 232 separated on a 4-15% bis-tris gel (Invitrogen, Nupage, NP0323) in MOPS buffer and blotted onto a 0.45 µm 233 nitrocellulose membrane (Amersham Biosciences, Hybond-ECL, Merck, GERPN303D). Ponceau Red 234 staining was performed for total protein analysis of ChemiDoc (BioRad) images in ImageLab software 235 (BioRad, v5.2.1). Membranes were blocked using 5% milk powder in TBS / 0.1% Tween20 (Merck, 655205-236 250ML). All antibodies are listed in Supplementary Table S2 . Membranes were washed five times using 
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MiRNome profiling identifies upregulation of miR-10b in RDEB-SCC
252
In order to identify differences in the miRNA expression profile between cultured primary keratinocytes (KC) 253 and cSCC cells (Supplementary Information and Supplementary Table S1 ), we conducted an Affymetrix Supplementary Fig. S1B ).
262
To assess the ability of the miRNA expression profiles to distinguish cSCCs from other experimental groups 263 we performed principal component analysis (PCA). Annotation of the samples within the distinct clusters 264 resulted in a clear separation of experimental groups ( Figure 1A) . Even though the miR-10 family was found 265 to be overall upregulated in cSCCs, in-depth analysis of major contributors driving the unsupervised cluster 266 separation highlighted miR-10b, which was 2.2-fold (p < 0.05) upregulated in RDEB-SCCs and 2.2-fold (p 267 < 0.05) in HC-cSCCs, respectively, compared to their non-malignant controls ( Figure 1B ,C). As opposed to 268 miR-10b, miR-10a was only found to be slightly upregulated by qPCR. As miR-10a appeared to be the most 269 deregulated miRNA in RDEB-SCCs in microarray analysis but not in subsequent qPCR, we assume that 270 high microarray scores most likely derived from a certain hybridization error rate (miRs-10a and -10b differ 271 in only one nucleotide) ( Figure 1E , Supplementary Fig. S1C-E ). In addition, increased miR-10b (9-fold) , but 272 not miR-10a, levels in RDEB-SCC were found in previously generated RNA sequencing (RNA-seq) data,
273
where immortalized HC-KC lines were used as controls ( Supplementary Fig. S1F,G) . Thus, we focused on 274 miR-10b, and dropped miR-10a from further experiments. Predicted miR-10b targets were further tested for 275 gene set enrichment in cancer hallmarks (Molecular Signature Database v6.2), and showed significant 276 association with metastatic processes like epithelial to mesenchymal transition (EMT) ( Figure 1D ).
277
In summary, the results of a microarray-based miRNA expression profiling revealed a deregulated 278 miRNome able to distinguish cSCC from keratinocytes. In particular, miR-10b was significantly upregulated 279 in cSCC.
281
Expression of miR-10b in cSCC tissues
282
In order to localize and further substantiate upregulation of miR-10b expression in tissue, we optimized a 283 combined IHC-ISH protocol using LNA probes. When tissue specific expression was examined in FFPE-284 sections of archival skin and tumor biopsies, miR-10b was found to be upregulated in cSCC, particularly in 285 RDEB-SCCs. Expression was predominantly co-localized to keratin-positive cells ( Figure 1F Supplementary Fig. S2D ). Notably, both 287 vasculature and hemopoietic cells have previously been shown to express miR-10b in a tumor context (15, 288 18, 27-29) . Further analysis of RDEB-tissues showed a strong expression of transcription factor TWIST1, a 289 known upstream driver of miR-10b-mediated tumor malignancy. In addition, TWIST1 was also found to be 290 upregulated in cultured SCC cells in IF and Western blot analysis ( Supplementary Fig. S2E,F) (14, 30) .
291
Single cells in an RDEB-SCC lymphnode metastasis (RDEB-SCC_LM) expressed high levels of miR-10b.
292
Less pronounced miR-10b abundance was observed in HC-cSCC ( Figure 1F ).
293
To investigate whether miR-10b expression was correlated to differentiation, cells were incubated in the 294 presence of calcium and serum in order to induce differentiation, and respective marker gene expression 295 was analyzed in parallel to miR-10b expression levels. However, no overall correlation between 296 differentiation and miR-10b expression was observed (data not shown).
297
Taken together, results of the IHC-ISH support a potential link between miR-10b expression levels and 298 aggressive RDEB-SCC. at distant niches (31). In order to investigate the biological role of miR-10b, we analyzed its expression 304 levels in experimental cell lines using IHC-ISH, in parallel to 3D tumor spheroid formation assays. As the 305 cytoplasm is considered as the site of miRNA maturation and action, fluorescence intensity, excluding the 306 nuclear region, was assessed at a single cell resolution. MiR-10b was confirmed to be highly expressed in 307 RDEB-SCC cell lines using ISH probes specific for mature miR-10b, and in two out of three HC-cSCC 308 cultures, as compared to primary HC-KCs (Figure 2A,B, Supplementary Fig. S3,4) . Notably, we observed 309 that miR-10b levels in cSCCs varied between individual cell lines, however, in correspondance to phenotypic 310 features linked to increased malignancy, like an EMT-associated spindle-like phenotype.
300
MiR-10b confers anchorage-independent aggregation capabilities to keratinocytes and attenuates
311
Next, we performed aggregate formation assays to explore the capacity of our cell lines to form anchorage 312 independent spheroids (32). All three RDEB-SCCs, and two out of three HC-cSCCs formed stable 313 aggregates ( Figure 2C,D) . Notably, KCs transduced with, and stably expressing miR-10b (KC miR-10b ) as 314 surrogate for downstream functional experiments, phenocopied RDEB-SCCs in the formation of stable 315 spheroids of 6.9×10 3 ± 1.1×10 3 µm 2 (≙ 90 µm diameter, RDEB-KC, Figure 2E ). Expression and maturation 316 of miR-10b, driven by the constitutive Pol-III U6 promoter, was confirmed by qPCR ( Supplementary Fig.   317 S5A). In addition, we found that KC miR-10b were significantly smaller than their parental cells (p-value RDEB-KC 318 = 0.002; p-value HC-KC < 0.001; Supplementary Fig. S6A ). Like in RDEB-SCC derived aggregates, viable cells 319 were found predominantly in the outer spheroid layers of KC miR-10b spheres ( Supplementary Fig. S5I ). Wild 320 type KCs formed fewer and rather loose aggregates, which did not withstand mild pipetting.
321
In order to further substantiate the link between miR-10b overexpression and enhanced spheroid formation 322 capacities, we next knocked-out the MIR10B gene locus in RDEB-SCC1 cells (RDEB-SCC1 MIR10B-/-) using 323 the CRISPR-Cas9 technology, and performed minimal dilution experiments to potentially obtain single 324 clones ( Supplementary Fig. S5J,K) . In spheroid formation assays we observed, that miR-10b knock-out 325 reduced the stability of aggregates and resulted in an increased number of single cells and fragmented 326 aggregates ( Figure 3A-C) . While PCR-mediated confirmation of MIR10B knock-out showed only bands 327 corresponding to successful deletion, we found that over time single cells that had escaped knock-out and 328 subsequent clearance by minimal dilution returned to dominance, independent of a potential proliferative 329 advantage ( Figure 3D 
334
Spheroids adhered to dishes, and circularly outgrowing cells became visible after 24 hrs in RDEB-SCC1 335 derived aggregates, and to a much lower extent in respective miR-10b knock-out cells. Again, this was 336 reversed in mixed culture experiments ( Figure 3F ). This outgrowth pattern was also observed in two out of 337 three HC-cSCC derived spheroid assays ( Figure 3G ).
338
As spheroid formation is a key attribute of cancer stem cells (CSCs), and points towards the presence of 339 cancer stem cell-like properties, we next analyzed accepted CSC markers (CD44 / CD24) (33). RDEB-SCC 340 cultures showed an overall high expression of CD44, and varying levels of CD24, including a CD44 high / 341 CD24 -/low cell population. In support of the hypothesis that miR-10b expression was associated with a CSC-342 like phenotype, overexpression of miR-10b in KCs resulted in an overall ~2-fold enrichment of CD44 high / 343 CD24 -/low cells ( Supplementary Fig. S6B ,C).
344
We next examined whether the above observed properties were attributed to mobility-, or adhesion-345 associated mechanisms (32). Therefore, we conducted wound closure assays using miR-10b 346 overexpressing (KC miR-10b ) and MIR10B knockout (RDEB-SCC1 MIR10B-/-) cells. We found that those cells 347 expressing high levels of miR-10b (i.e. RDEB-KC miR-10b versus parental, SCC1 MIR10B-/versus parental) 348 demonstrated significantly impaired mobilization (time point 6 hrs: p < 0.01) ( Figure 4A,B ). In addition, when 349 transiently transfecting SCC1 MIR10B-/with a miR-10b mimic, as well as when using the mixed population, gap 
352
Taken together, our data suggest for the first time that CSC-like properties can be conferred by miR-10b, a 353 heretofore unknown aspect of miR-10b driven malignancy in cSCCs.
355
DIAPH2 is deregulated in RDEB-SCC and predicted to be a target of miR-10b 356
To analyze the impact of miR-10b on its targetome, we first screened the scientific literature in an automated 357 text-mining approach for miR-10b in cancer, which highlighted the previously reported, direct miR-10b target 358 transcription factor HOXD10 (14, Supplementary Fig. S7A ). We observed significantly reduced levels of 359 HOXD10 protein in three RDEB-SCC cell lines compared to HC-KC, and also in an RDEB-SCC tissue 360 section, compared to HC-and RDEB-skin (34, Supplementary Fig. S7B-D) .
361
To next identify novel downstream targets of miR-10b by the example of RDEB, data driven miR-10b target 362 identification was implemented based on transcriptome data generated from miRNA microarray-matched 363 RDEB-SCC and RDEB-KC samples. Of the 576 differentially expressed genes identified (≥ 2-fold ↓↑) in 364 RDEB-SCCs, 114 were reported in merged repository data (n = 3,923) of validated miR-10 targets 365 (miRTarbase v6.1), as well as computationally predicted targets by seed sequence and evolutionary 366 conservation (TargetScan v7.2). Dysregulated putative miR-10 interaction partners were further prioritized 367 by strength of their inverse correlation of expression with miR-10 signal ( Supplementary Fig. S7E ). To 368 nominate a disease relevant miR-10b target, we analyzed publicly available survival data from metastatic 369 stage IV head and neck squamous cell carcinoma (HNSCC) (n = 86 patients, The Cancer Genome Atlas / 370 TCGA), as this cancer type was previously described to have high genetic similarities to RDEB-SCC (8).
371
The top 20 candidate miR-10b targets with highest inverse correlation were then used to stratify HNSCC 372 patients ( Supplementary Fig. S8A and Supplementary Table S6 ). We nominated diaphanous related formin 373 2 (DIAPH2) for further evaluation based on significant differences in Kaplan Meier survival curves (p < 0.05, 374 log-rank test, Figure 5A ), together with the fact that it was listed as a putative target of miR-10b. Its potential 375 disease-relevance was substantiated by its recent association with colon carcinoma, and its potential role 376 in actin-organization and microtubule stabilization (35) (36) (37) . When re-analyzing normalized RNA-seq data 377 generated by Cho et al., retrieved from GEO-repository (GSE111582), both, DIAPH2 and HOXD10, showed 378 lower expression in RDEB-SCC versus RDEB-skin tissue (8, Supplementary Fig. S8B,C) . DIAPH2 was also 379 slightly downregulated in KC miR-10b as shown by sqRT-PCR ( Supplementary Fig. S5B ). However, when 380 analyzing DIAPH2 protein expression in KC miR-10b and RDEB-SCC MIR10B-/by Western blot analysis and 381 immunofluorescence, results were not conclusive, pointing towards the impact of further regulatory 382 mechanisms influencing DIAPH2 expression (data not shown).
383
To confirm DIAPH2 as a direct target of miR-10b, a dual luciferase reporter assay was established by cloning 384 the 3'UTRs of DIAPH2 and HOXD10 as a control, respectively, downstream of a firefly luciferase reporter 385 gene. Constructs were then co-transfected with a miR-10b mimic into HC-KCs, which express only low 386 levels of endogenous miR-10b. In the presence of miR-10b mimic, luciferase signal was significantly 387 reduced (p-value DIAPH2 = 0.015; p-value HOXD10 < 0.01) compared to scrambled (SCR) control (Supplementary 388 Fig. S7F,G) .
389
We next assessed DIAPH2 expression in cultured RDEB-and control KC. Both, at the mRNA and the 390 protein level, DIAPH2 was downregulated in RDEB-SCC cells ( Supplementary Fig. S7I, Figure 5B ,C).
391
Notably, following transient transfection of HC-KCs with miR-10b mimic, DIAPH2 protein levels were found 392 to be significantly reduced (~29%, p = 0.005) compared to SCR control ( Supplementary Fig. S7H ). DIAPH2 393 downregulation was also evident in RDEB-SCC tissue sections ( Figure 5D ).
394
To examine if a loss of DIAPH2 in keratinocytes phenocopies the observed migratory behavior in KC miR-10 , 395 we knocked out DIAPH2 using the CRISPR/Cas9 technology (1090KC DIAPH2-/-). Clones were generated by 396 minimal dilution and knock-out was confirmed by Sanger sequencing and Western blot analysis 397 ( Supplementary Fig. S5C,D) . While proliferation was not altered, DIAPH2-/-cells showed significantly 398 impaired motility over HC-KCs ( Supplementary Fig. S5E,F) . In addition, when analyzing HC-KC DIAPH2-/in a 399 3D-sphere formation assay, a trend towards enhanced aggregation was observed, with a distribution of 400 spheroid size similar to cSCCs ( Supplementary Fig. S5G,H) . The functional impact of DIAPH2 knock-out 401 resembled our observations in miR-10b overexpressing KCs.
402
Our work taken as a whole has demonstrated that miR-10b is overexpressed in cSCC cells and tissues, 403 and that miR-10b confers tumor-associated properties to KCs. In addition, deregulation of DIAPH2, a novel 404 putative miR-10b downstream target, might represent a contributing factor in cSCC malignancy.
406
Discussion
407
Various factors are presumed to contribute to the development of SCCs in RDEB patients, however, the 408 role of miRNAs in the context of RDEB has not yet been addressed. In this study, our aim was to identify 409 miRNAs involved in development or progression of particularly aggressive cSCCs, by profiling the miRNome 410 of human cSCCs, as well as keratinocytes. As miR-10b was found to be significantly upregulated in cSCC 411 in vitro and in situ we next examined its functional impact on normal human keratinocytes. Contrary to initial 412 expectations keratinocytes overexpressing miR-10b migrated more slowly and showed no differences in 413 proliferation and / or invasive potential compared to controls. However, the overexpression of miR-10b 414 improved the ability of cells to form stable 3D-spheroids: a capacity for anchorage-independent survival, 415 generally attributed to cells with the potential to initiate tumor growth, such as CSCs -which resembled 416 those derived from aggressive cSCC cells. This shift towards stemness upon miR-10b overexpression in 417 keratinocytes was confirmed through an enrichment of CD44 high / CD24 -/low cells (38). Unfortunately, tumor 418 initiation experiments in immunodeficient mice did not result in the engraftment of cells, or the development 419 of a tumor, likely due to their overall non-malignant background of RDEB keratinocytes. Notably, not all 420 RDEB-SCC lines are able to successfully engraft in immunodeficient mice, highlighting that other factors, 421 such as a supportive microenvironment, are required.
422
However, the observation that miR-10b is overexpressed and may have a functional role in mediating 423 stemness does highlight a novel aspect of miR-10b function in cSCC, that is separate from its well 424 demonstrated role in EMT.
425
While it has been repeatedly reported that EMT is necessary for cells to disseminate from the primary tumor 426 and become circulating tumor cells (CTCs), complementary models of metastasis exist (31, 39). One pre-427 requisite for CTCs is to maintain their ability to revert from the mesenchymal to the epithelial phenotype 428 (MET). Another is based on the concept of "collective" or "cohort" migration. In this case it is assumed that 429 epithelial-like and mesenchymal-like cancer cells circulate in clusters and act cooperatively to promote 430 metastatic growth, without the need to undergo complete EMT/MET (40). Ultimately, a key event during 431 metastasis is that cells with a tumor-initiating capacity reach and establish at distant sites to form new 432 colonies, which requires cell adhesion (31). We hypothesize that the increased adhesive potential and 433 sphere formation capacity following overexpression of miR-10b, might not only increase cell survival in the 434 circulation, but also facilitate extravasation at new sites, and explains in part the propensity of aggressive 435 cSCCs to metastasize (41).
436
Alternatively, changes in the actin-and / or microtubule cytoskeleton, which impact cell motility (42), could 437 account for slower wound closure rates and increased stickiness in RDEB skin. In this context, the putative 438 miR-10b target DIAPH2, a protein belonging to the formin homology family, which has previously been 439 associated with actin filament assembly, microtubule formation and vesicle shuttling, might be a modulator 440 of cell motility in 44) . In this study, DIAPH2 was predicted to be a target of miR-10b in 441 silico, which we additionally confirmed using a luciferase-reporter assays. Notably, while miR-10b 442 overexpression did not result in efficient knock-down of DIAPH2 in RDEB-KCs, a significant downregulation (46). DIAPH2 is predicted to interact with small RHO-GTPases, which are implicated in 451 motility, and frequently downregulated in different types of SCCs (47, 48) . In line with this, our microarray 452 data also indicate a slight downregulation of RHOC and RHOD in RDEB-SCC. Considering this, a similar 453 function of DIAPH2 in the context of SCCs is likely but needs to be further explored. However, while we 454 could show that DIAPH2 is a potential target of miR-10b by luciferase assays, and expression levels can be 455 correlated to miR-10b expression in patient samples, it seems that also other regulatory networks impact 456 DIAPH2 expression, as downregulation was not conclusive in miR-10b overexpressing cells. Therefore, 457 regulatory networks affecting DIAPH2 expression and its biological role will need further investigation in the 458 future.
459
In summary, overexpression of miR-10b impacts cellular processes at various levels. The extent of the 460 response is dependent on the cellular context, the presence of certain target mRNAs, and/or mutations in 461 those target mRNAs (49). In the context of cSCCs, we showed that miR-10b confers anchorage-462 independent spheroid formation capacities, indicating a phenotypic shift towards stem cell-like properties.
463
We hypothesize, that these findings might be involved in tumor progression at the stages of extravasation 464 and metastatic colonization, processes in which both anchorage-free survival, as well as cell surface 465 interaction, are important pre-requisites.
467
Conclusion
468
Overall, our results demonstrate for the first time the upregulation of miR-10b in aggressive RDEB-SCCs.
469
While new, these findings provide a potential so far unreported pro-metastatic function of miR-10b, as this The data that support the findings of this study were submitted to the Gene Expression Omnibus Database 525 (Accession: GSE130767 for miRNA and GSE130925 for transcriptome microarray data 
